Why Northwestern?
At the Polsky Urologic Cancer Institute, our physicians adopt the personalized, multidisciplinary approach to care that flourishes at Northwestern Medicine, and our scientists are committed to driving transformative new insights and successes in urologic cancer research, education and discovery. It is our goal to give patients the best chance of overcoming urologic cancer and future generations the hope of never developing it.
Clinical Activities
Leadership
The institute consists of expert physicians and scientists who are dedicated to making Northwestern the world’s leader in diagnosing, advancing research breakthroughs and creating revolutionary treatments for urological cancers.
The Polsky Urologic Cancer Institute is a multidisciplinary access point for cancer care, including imaging, surgery, chemo-, radio- and immunotherapy as well as a resource for cancer genetics, survivorship and lifestyle management.”
Maha Hussain, MD, FACP, FASCO
Professor of Medicine, Deputy Director and GU Oncology Program Leader, Lurie Cancer Center
Ashley Ross, MD, PhD
Professor, Clinical Director, Polsky Urologic Cancer Institute, Department of Urology, Co-Director Northwestern Urology Robotic Surgery and Minimally Invasive Urologic Oncology ProgramOur Thanks
The Polsky Urologic Cancer Institute owes its creation to a generous gift from energy entrepreneur and longtime Northwestern Medicine supporter Michael Polsky, CEO of Invenergy. Polsky says the gift “symbolizes my family’s commitment to help others facing cancer come out on the winning side.” To make your own gift in support of our urologic cancer programs, please contribute today.
DONATE